Neurocognitive Outcome After Coronary Artery Bypass Surgery Using Minimal

Status Completed

Clinical Trial Summary

The aim of this study is to assess the effect of minimal (MECC) versus conventional (CECC) extracorporeal circulation on neurocognitive function after elective coronary bypass grafting (CABG) as well as whether this can be attributed to improved cerebral perfusion intraoperatively.

Clinical Trial Description

Despite improvements in the biocompatibility of cardiopulmonary bypass (CPB) circuits, the activation of inflammatory systemic response can result in clinically relevant organ dysfunction. Regarding the central nervous system, prolonged hypoperfusion and microembolization during conventional CPB have been related to postoperative neurologic impairment with an incidence varying from 30% to 60%. This clinical scenario covers a spectrum from a transient subtle cognitive dysfunction to a permanent stroke. Postoperative cognitive decline (POCD) is characterized as impairment in attention, cognition, recognition, orientation, memory, and learning. It may result in prolonged hospitalization, increased morbidity and mortality, while it has an adverse impact on quality of life after surgery.

Near-infrared spectroscopy (NIRS) provides a continuous and noninvasive monitoring of regional cerebral oxygen saturation (rSO2). Recent studies have shown a significant relationship between intraoperative cerebral oxygen desaturation, indicative of cerebral ischemia, and early POCD in patients undergoing elective coronary bypass grafting (CABG) with conventional extracorporeal circulation (CECC). In an attempt to reduce CPB-inherent side effects, a minimal extracorporeal circulation (MECC) system was developed and it is evaluated in clinical practice. The aim of this pilot study was to define whether there is a difference in early postoperative neurocognitive functioning between patients being operated for CABG on MECC versus CECC systems as well as whether this can be attributed to improved cerebral perfusion intraoperatively. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Coronary Artery Bypass

Clinical Trial Details

NCT number	NCT01213511
Study type	Interventional
Source	AHEPA University Hospital
Contact
Status	Completed
Phase	N/A
Start date	January 2009
Completion date	June 2012

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03235323` - Efficacy of External CounterPulsation for Postoperative Coronary Artery Bypass Grafting Patients	N/A
Completed	`NCT05036044` - Stroke and Carotid-Cerebral Vascular Disease After CABG
Recruiting	`NCT05010460` - Study of Roxadustat for Reducing the Incidence of Acute Kidney Injury After Coronary Artery Bypass Grafting	Phase 2
Completed	`NCT03622671` - Fibrin Clot Properties and Blood Loss Following Coronary Artery By-pass Grafting	N/A
Completed	`NCT00400790` - Organ Protection for Coronary Artery Bypass Graft (CABG): Propofol Versus Desflurane	N/A
Not yet recruiting	`NCT03275220` - Assessment Of Right Ventricular Function In Patients Undergoing Coronary Artery Bypass Graft In Assiut University	N/A
Completed	`NCT01256372` - An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery	Phase 2
Completed	`NCT00489827` - Glutamate for Metabolic Intervention in Coronary Surgery	Phase 3
Completed	`NCT04591119` - Transversus Thoracis Muscle Plane Block for Postoperative Pain in Adult Cardiac Surgery	N/A
Active, not recruiting	`NCT03908593` - Proton Pump Inhibitor Preventing Upper Gastrointestinal Injury In Patients On Dual Antiplatelet Therapy After CABG	Phase 4
Recruiting	`NCT03774342` - The Influence of Cognitive Decline on Quality of Life After Coronary Bypass
Enrolling by invitation	`NCT03999398` - Short and Long-term Results of PCI in no Touch Vein-graft.
Recruiting	`NCT05414331` - WithDRawal Impact Of Postoperative Beta-Blocker	N/A
Completed	`NCT02981680` - Effect of Remote Ischemic Preconditioning on the Incidence of Acute Kidney Injury in Patients Undergoing Coronary Artery Bypass Graft Surgery	N/A
Completed	`NCT00600704` - Impact of Fluid Restriction Policy in Reducing the Use of Red Cells in Cardiac Surgery	N/A
Completed	`NCT06013605` - Effect of Walking Exercise on Functional Capacity and Productivity in Patients After Coronary Artery Bypass Graft	N/A
Active, not recruiting	`NCT02731794` - On-pump Beating Coronary Artery Bypass Grafting by Ventricular Assist	Phase 4
Completed	`NCT02722213` - Mindfulness & Stress Management Study for Cardiac Patients	N/A
Completed	`NCT01285271` - A Pre- and Post- Coronary Artery Bypass Graft Implantation Disposed Application of Xenon	Phase 3
Completed	`NCT00911976` - Study of the Xience V Everolimus-eluting Stent in Saphenous Vein Graft Lesions	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Neurocognitive Outcome After Coronary Artery Bypass Surgery Using Minimal Versus Conventional Extracorporeal Circulation

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms